Chromatographia

, Volume 56, Issue 1, pp S131–S135 | Cite as

Unknown residual solvents identification in drug products by headspace solid phase microextraction gas chromatography-mass spectrometry

  • C. C. Camarasu
Originals Gas Chromatography
Received:
Revised:
Accepted:

Summary

A sensitive headspace SPME method for the extraction of residual solvents from pharmaceutical products has been developed and optimized. It was found that minimizing sample and headspace volume has a beneficial effect on extraction efficiency. At the same time the method reproducibility was seriously affected by reducing sample and headspace volume. The added air volume was not found to have any significant influence on method sensitivity. The method showed reproducibilities of less than 10% and detection limits as low as 1 ppb for benzene and dichloromethane. The headspace SPME method is around 1000 times more sensitive than static headspace. The optimized parameters were headspace volume 1.5 mL, sample volume 10 μL, and extraction time 30 min. The method was successfully applied to the identification of unknown residual solvents in three different proprietary active drug substances and was successfully applied to the confirmation of the presence of benzene in a proprietary drug substance.

Key Words

Gas chromatography-Mass spectrometry Solid phase microextraction Pharmaceutical products Residual solvents 
This is a preview of subscription content, log in to check access.

References

  1. [1]
    Arthur, L.C.; Pawliszyn, J.Anal. Chem. 1990,62, 2145–2148.CrossRefGoogle Scholar
  2. [2]
    Zhang, Z.; Pawliszyn, J.J. High Resol. Chromatogr. 1996,19, 155–160.CrossRefGoogle Scholar
  3. [3]
    Shirey, R.J. High Resol. Chromatogr. 1995,18, 495–499.CrossRefGoogle Scholar
  4. [4]
    Martos, P.A.; Pawliszyn, J.Anal. Chem., 69, 206–215.Google Scholar
  5. [5]
    Pan, L.; Pawliszyn, J.Anal. Chem. 1997,69, 196–205.CrossRefGoogle Scholar
  6. [6]
    Górecki, T.; Pawliszyn, J.J. High Resol. Chromatogr. 1995,18, 161–166.CrossRefGoogle Scholar
  7. [7]
    Morcillo, Y.; Cai, Y.; Bayona, J.M.J. High Resol. Chromatogr. 1995,18, 767–770.CrossRefGoogle Scholar
  8. [8]
    Grote, C.; Pawliszyn, J.Anal. Chem. 1997,69, 587–598.CrossRefGoogle Scholar
  9. [9]
    Moens, L.; Smaele, T.D.; Dams, R.; Broeck, P.V.D.; Sandra, P.Anal. Chem. 1997,69, 1604–1611.CrossRefGoogle Scholar
  10. [10]
    Lkso, H.; Ng, W.F.Anal. Chem. 1997,69, 1866–1872.CrossRefGoogle Scholar
  11. [11]
    Fromberg, A.; Nilsson, T.; Larsen, B.R.: Montanarella, L.; Facchetti, S.; Madsen, J.O.J. Chromatogr. 1996,746, 71–81.CrossRefGoogle Scholar
  12. [12]
    Page, B.; Lacroix, G.J. Chromatogr. 1993,648, 199–211.CrossRefGoogle Scholar
  13. [13]
    Shaw, R.; Smith, S.A.-M.; Nelson, C.; Scypinski, S. poster presentation, American Association of Pharmaceutical Science Conference, June1994.Google Scholar
  14. [14]
    Camarasu, C.; Mezei, M.; Szabó, A.Acta Pharmaceutica Hungarica 1999,69, 77–84.Google Scholar
  15. [15]
    Camarasu, C.C.; Mezei-Szucs, M.; Varga, G.B.J. Pharm. Biomed. Anal. 1998,18, 623–638.CrossRefGoogle Scholar
  16. [16]
    Camarasu, C.C.J. Pharm. Biomed. Anal. 2000,23, 197–210.CrossRefGoogle Scholar
  17. [17]
    Camarasu, C.C.Chromatographia 2002,56 (Suppl.), 137–143.CrossRefGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 2002

Authors and Affiliations

  • C. C. Camarasu
    • 1
  1. 1.Gedeon Richter LtdCentral Analytical LaboratoryBudapestHungary

Personalised recommendations